Ischaemic heart disease incidence rates per 10 000 person-year (PY) of follow-up by exposure status
| Variables | Unexposed | ILD combined | PS | PF | ||||||||
| N | PY | Rate* (95% CI) | N | PY | Rate* (95% CI) | N | PY | Rate* (95% CI) | N | PY | Rate* (95% CI) | |
| Overall | 56 884 | 291 098 | 39.71 (37.49 to 42.07) | 11 688 | 58 064 | 57.35 (51.51 to 63.85) | 4568 | 31 849 | 20.09 (15.73 to 25.67) | 7120 | 26 215 | 102.61 (91.06 to 115.64) |
| Sex | ||||||||||||
| Male | 31 854 | 151 493 | 52.74 (49.21 to 56.53) | 6291 | 29 209 | 78.06 (68.56 to 88.88) | 2313 | 15 471 | 20.68 (14.63 to 29.25) | 3978 | 13 737 | 142.68 (124.03 to 164.12) |
| Female | 25 030 | 139 605 | 25.57 (23.05 to 28.37) | 5397 | 28 855 | 36.39 (30.05 to 44.06) | 2255 | 16 377 | 19.54 (13.82 to 27.67) | 3142 | 12 477 | 58.51 (46.51 to 73.59) |
| Age (years) | ||||||||||||
| <50 | 12 272 | 94 514 | 6.35 (4.93 to 8.18) | 3075 | 22 579 | 9.74 (6.42 to 14.80) | 2691 | 20 210 | 7.42 (4.47 to 12.31) | 384 | 2369 | 29.55 (14.09 to 61.98) |
| 50–59 | 7460 | 48 513 | 24.94 (20.87 to 29.81) | 1759 | 10 841 | 37.82 (27.85 to 51.36) | 1047 | 7098 | 29.59 (19.29 to 45.38) | 712 | 3740 | 53.43 (34.47 to 82.82) |
| 60–69 | 11 321 | 57 927 | 50.06 (44.62 to 56.17) | 2308 | 10 638 | 98.70 (81.52 to 119.51) | 568 | 3367 | 62.37 (40.67 to 95.66) | 1740 | 7271 | 115.52 (93.28 to 143.07) |
| 70–79 | 15 392 | 60 369 | 79.68 (72.86 to 87.12) | 2759 | 9460 | 130.03 (108.96 to 155.16) | 210 | 1006 | 59.61 (26.78 to 132.69) | 2549 | 8453 | 138.41 (115.47 to 165.91) |
| >80 | 10 438 | 29 774 | 68.52 (59.73 to 78.59) | 1786 | 4546 | 92.39 (68.28 to 125.02) | 52 | 168 | 59.56 (8.39 to 422.79 | 1735 | 4377 | 93.65 (68.96 to 127.19) |
ILD, interstitial lung disease; PF, pulmonary fibrosis; PS, pulmonary sarcoidosis.